Skip to main content

Table 1 Summary of data in patients with thyroid lesion

From: Rapid detection of papillary thyroid carcinoma by fluorescence imaging using a γ-glutamyltranspeptidase-specific probe: a pilot study

Patient Age Sex Preoperative clinical diagnosis Pathological diagnosis gGlu-HMRG*a lesion normal
1 30 F PTC*b PTC positive negative
2 32 F PTC PTC positive negative
3 46 F PTC (recurrence) PTC(recurrence) positive negative
4 55 F Thyroid malignant tumor Mediastinal goiter negative negative
5 78 M Lymphoma Inflammation negative negative
6 43 F PTC PTC positive negative
7 47 F Thyroid tumor Follicular adenoma negative negative
8 47 F PTC PTC positive negative
9 44 F PTC PTC positive negative
10 61 F PTC PTC positive negative
11 32 F PTC PTC positive negative
12 48 M PTC PTC positive negative
13 23 F Thyroid tumor Goiter*c negative negative
14 44 M PTC PTC positive negative
15 58 F Thyroid tumor Goiter negative negative
16 72 F PTC PTC positive negative
17 57 M PTC PTC positive negative
18 68 F Thyroid lesion Graves’*d negative negative
19 71 F PTC PTC negative negative
20 55 F PTC PTC positive negative
21 52 F PTC PTC positive negative
22 69 M Goiter Goiter negative negative
23 64 M PTC PTC positive negative
  1. *agGlu-HMRG: detection results by using γ- glutamyl hydroxymethyl rhodamine green, *bPTC: Papillary thyroid carcinoma,
  2. *cGoiter: Adenomatous goiter, *dGraves’: Graves’ disease or Basedow disease